<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-FCQ3GBDZ</identifier><date>2014</date><creator>Schreiter, Nils F.</creator><relation>documents/doc/F/URN_NBN_SI_doc-FCQ3GBDZ_001.pdf</relation><relation>documents/doc/F/URN_NBN_SI_doc-FCQ3GBDZ_001.txt</relation><format format_type="issue">4</format><format format_type="volume">48</format><format format_type="type">article</format><format format_type="extent">str. 339-347, I</format><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">279585536</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-FCQ3GBDZ</identifier><language>eng</language><language>slv</language><publisher>Association of Radiology and Oncology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="eng">diagnostika</subject><subject language_type_id="slv">nevroendokrini tumorji</subject><subject language_type_id="slv">radiološka diagnostika</subject><title>evaluation of Ga-68 DOTATOC PET/CT and In-111 DTPA octreotide SPECT/CT</title><title>Searching for primaries in patients with neuroendocrine tumors (NET) of unknown primary and clinically suspected NET</title></Record>